Cytokinetics to Host Investor & Analyst Day on October 16, 2024
Cytokinetics Inc CYTK
News
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
Cytokinetics Announces Data From Phase 1 Study of CK-4021586
Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the European Society of Cardiology Congress 2024
Cytokinetics Reports Second Quarter 2024 Financial Results
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cytokinetics Announces Call for Proposals for Corporate Giving Program
Cytokinetics to Announce Second Quarter Results on August 8, 2024
Cytokinetics Announces Seven Upcoming Presentations at the European Society of Cardiology Congress 2024
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout
This biotech ETF sees 'breakout' while U.S. small-cap technology stocks lag
Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal
Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal
Novartis, Cytokinetics near merger: report
United States